This study is designed to investigate the safety, tolerability and pharmacokinetics of inhaled CHF6523 DPI in healthy male subjects first...
The purpose of this study is to find the best dose of RPL554 for treating the symptoms of COPD. COPD...
The purpose of the study is to demonstrate the non-inferiority of CHF1535 pMDI versus Symbicort® Turbohaler® in terms of lung...
The purpose of this study is to support the dose selection for future studies by evaluating efficacy and safety of...
A clinical study to investigate if a single dose of an approved drug product (glycopyrrolate Inhalation Solution) reduces trapped air...
Primary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate-or ...
Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD...
This is a multicenter, randomized, double-blind, placebo-controlled, 30-week, adaptive cross-over study, with a Treatment Period of approximately 26 weeks under...
To compare the efficacy of acapella and expiration against open glottis (ELTGOL) technique in promoting airway clearance of chronic obstructive...
The purpose of this study is to evaluate the efficacy of ARALAST NP A1PI augmentation therapy 120 milligrams per kilogram...
English (USA)